The risk or severity of adverse effects can be increased when MOLINDONE is combined with amoxapine.


The risk or severity of adverse effects can be increased when Limaprost is combined with epoprostenol.


The risk or severity of adverse effects can be increased when nicardipine is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with efavirenz.


The risk or severity of adverse effects can be increased when fenbufen is combined with fluocinonide.


The risk or severity of adverse effects can be increased when venlafaxine is combined with Almotriptan.


The risk or severity of adverse effects can be increased when Carbetocin is combined with Nebivolol.


The risk or severity of adverse effects can be increased when ramipril is combined with mycophenolate mofetil.


The risk or severity of adverse effects can be increased when Tapentadol is combined with potassium ion.


The risk or severity of adverse effects can be increased when Torasemide is combined with ribostamycin.


The risk or severity of adverse effects can be increased when rescinnamine is combined with BALSALAZIDE.


The risk or severity of adverse effects can be increased when terbutaline is combined with MEPHENTERMINE.


The risk or severity of adverse effects can be increased when terbutaline is combined with Ephedrine.


The risk or severity of adverse effects can be increased when terbutaline is combined with PROCATEROL.


The risk or severity of adverse effects can be increased when Olmesartan is combined with nifedipine.


The risk or severity of adverse effects can be increased when isoproterenol is combined with clenbuterol.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with topiramate.


The risk or severity of adverse effects can be increased when Nabilone is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when tolnaftate is combined with Pregabalin.


The risk or severity of adverse effects can be increased when nitrazepam is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when bumetanide is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Lurasidone.


The risk or severity of adverse effects can be increased when nicergoline is combined with erythromycin.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with vigabatrin.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with sotalol.


The risk or severity of adverse effects can be increased when phentolamine is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when amiodarone is combined with lisinopril.


The risk or severity of adverse effects can be increased when nicergoline is combined with Tramadol.


The risk or severity of adverse effects can be increased when quetiapine is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when gabapentin is combined with Desloratadine.


The risk or severity of adverse effects can be increased when butabarbital is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when gabapentin is combined with mepivacaine.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with Torasemide.


The risk or severity of adverse effects can be increased when reserpine is combined with HEROIN.


The risk or severity of adverse effects can be increased when ethosuximide is combined with citalopram.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with Nebivolol.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with Articaine.


The risk or severity of adverse effects can be increased when maprotiline is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when ramipril is combined with minoxidil.


The risk or severity of adverse effects can be increased when Dexrazoxane is combined with clozapine.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with spironolactone.


The risk or severity of adverse effects can be increased when Tramadol is combined with hydromorphone.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with HEROIN.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with metoclopramide.


The risk or severity of adverse effects can be increased when memantine is combined with methacholine.


The risk or severity of adverse effects can be increased when Tramadol is combined with Tolcapone.


The risk or severity of adverse effects can be increased when enalapril is combined with lisinopril.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with sevoflurane.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when oxybutynin is combined with nalbuphine.


The risk or severity of adverse effects can be increased when VERAPAMIL is combined with losartan.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with bromocriptine.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when Icatibant is combined with epirizole.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with sertraline.


The risk or severity of adverse effects can be increased when isradipine is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when methylprednisolone is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when meprobamate is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when ketamine is combined with tizanidine.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when Ramelteon is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when reserpine is combined with oxycodone.


The risk or severity of adverse effects can be increased when reserpine is combined with buspirone.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with nefazodone.


The risk or severity of adverse effects can be increased when reserpine is combined with fosinopril.


The risk or severity of adverse effects can be increased when diflorasone is combined with decamethonium.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with zotepine.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with MELPERONE.


The risk or severity of adverse effects can be increased when bromazepam is combined with enflurane.


The risk or severity of adverse effects can be increased when Lopinavir is combined with disulfiram.


The risk or severity of adverse effects can be increased when MELPERONE is combined with Retigabine.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with tetracaine.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when ethopropazine is combined with ANISOTROPINE METHYLBROMIDE.


The risk or severity of adverse effects can be increased when nortriptyline is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when methocarbamol is combined with zonisamide.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with clonazepam.


The risk or severity of adverse effects can be increased when venlafaxine is combined with dicumarol.


The risk or severity of adverse effects can be increased when bifonazole is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Melatonin.


The risk or severity of adverse effects can be increased when selegiline is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Eplerenone.


The risk or severity of adverse effects can be increased when triflupromazine is combined with thiamylal.


The risk or severity of adverse effects can be increased when selegiline is combined with bumetanide.


The risk or severity of adverse effects can be increased when triflupromazine is combined with desipramine.


The risk or severity of adverse effects can be increased when estazolam is combined with meclizine.


The risk or severity of adverse effects can be increased when Eprosartan is combined with Apremilast.


The risk or severity of adverse effects can be increased when quetiapine is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when apomorphine is combined with Metipranolol.


The risk or severity of adverse effects can be increased when perphenazine is combined with ethosuximide.


The risk or severity of adverse effects can be increased when cabergoline is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when Atomoxetine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when antipyrine is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with tioconazole.


The risk or severity of adverse effects can be increased when enalapril is combined with Nebivolol.


The risk or severity of adverse effects can be increased when thiamylal is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when pentobarbital is combined with oxprenolol.


The risk or severity of adverse effects can be increased when bupivacaine is combined with losartan.


The risk or severity of adverse effects can be increased when apomorphine is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when Carbetocin is combined with papaverine.


The risk or severity of adverse effects can be increased when methyldopa is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when Carbetocin is combined with nifedipine.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Miltefosine.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with Pentolinium.


The risk or severity of adverse effects can be increased when thiothixene is combined with Articaine.


The risk or severity of adverse effects can be increased when celecoxib is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when pentazocine is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with carprofen.


The risk or severity of adverse effects can be increased when pentazocine is combined with ondansetron.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with METAXALONE.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with Fospropofol.


The risk or severity of adverse effects can be increased when desipramine is combined with clomipramine.


The risk or severity of adverse effects can be increased when desipramine is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when zaleplon is combined with thiothixene.


The risk or severity of adverse effects can be increased when zopiclone is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with oxaprozin.


The risk or severity of adverse effects can be increased when tizanidine is combined with flunarizine.


The risk or severity of adverse effects can be increased when brotizolam is combined with meclizine.


The risk or severity of adverse effects can be increased when ketorolac is combined with desoximetasone.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Amrubicin.


The risk or severity of adverse effects can be increased when diazepam is combined with benzocaine.


The risk or severity of adverse effects can be increased when Lercanidipine is combined with triamterene.


The risk or severity of adverse effects can be increased when diazepam is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when diazepam is combined with vigabatrin.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when pentobarbital is combined with maprotiline.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when pentobarbital is combined with mesoridazine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with nifedipine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with NAPROXEN.


The risk or severity of adverse effects can be increased when meperidine is combined with chlordiazepoxide.


The risk or severity of adverse effects can be increased when sulindac is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when Lofexidine is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when LISURIDE is combined with resveratrol.


The risk or severity of adverse effects can be increased when enflurane is combined with protriptyline.


The risk or severity of adverse effects can be increased when cocaine is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when halothane is combined with Nitroprusside.


The risk or severity of adverse effects can be increased when clorazepate is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when halothane is combined with Tolcapone.


The risk or severity of adverse effects can be increased when halothane is combined with amitriptyline.


The risk or severity of adverse effects can be increased when Masoprocol is combined with indomethacin.


The risk or severity of adverse effects can be increased when gabapentin is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when Tedizolid phosphate is combined with Asenapine.


The risk or severity of adverse effects can be increased when suprofen is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when suprofen is combined with Salsalate.


The risk or severity of adverse effects can be increased when isoxsuprine is combined with DOXOFYLLINE.


The risk or severity of adverse effects can be increased when cilnidipine is combined with MAGNESIUM HYDROXIDE.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when Torasemide is combined with nimodipine.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when desoximetasone is combined with sparfloxacin.


The risk or severity of adverse effects can be increased when Atazanavir is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when barnidipine is combined with valsartan.


The risk or severity of adverse effects can be increased when barnidipine is combined with pravastatin.


The risk or severity of adverse effects can be increased when quetiapine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when Toloxatone is combined with lithium ion.


The risk or severity of adverse effects can be increased when barnidipine is combined with ramipril.


The risk or severity of adverse effects can be increased when ioxilan is combined with metformin.


The risk or severity of adverse effects can be increased when thiamylal is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when Torasemide is combined with clonidine.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with amcinonide.


The risk or severity of adverse effects can be increased when Torasemide is combined with propranolol.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when lisinopril is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when Calcium citrate is combined with ceftriaxone.


The risk or severity of adverse effects can be increased when Flupentixol is combined with Perospirone.


The risk or severity of adverse effects can be increased when nabumetone is combined with leflunomide.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when butenafine is combined with diltiazem.


The risk or severity of adverse effects can be increased when linezolid is combined with droperidol.


The risk or severity of adverse effects can be increased when tolmetin is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when CLOBETASOL PROPIONATE is combined with NEOSTIGMINE.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with zotepine.


The risk or severity of adverse effects can be increased when ketorolac is combined with epirizole.


The risk or severity of adverse effects can be increased when promazine is combined with Perospirone.


The risk or severity of adverse effects can be increased when nicergoline is combined with azelastine.


The risk or severity of adverse effects can be increased when bumetanide is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with Pizotifen.


The risk or severity of adverse effects can be increased when Bismuth subcitrate potassium is combined with misoprostol.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with Difenoxin.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with Tixocortol.


The risk or severity of adverse effects can be increased when floctafenine is combined with chloroquine.


The risk or severity of adverse effects can be increased when nitric oxide is combined with pramipexole.


The risk or severity of adverse effects can be increased when Efonidipine is combined with apraclonidine.


The risk or severity of adverse effects can be increased when thiothixene is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when Vildagliptin is combined with lisinopril.


The risk or severity of adverse effects can be increased when clorazepate is combined with Pramocaine.


The risk or severity of adverse effects can be increased when atenolol is combined with benazepril.


The risk or severity of adverse effects can be increased when zopiclone is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when Treprostinil is combined with salicylamide.


The risk or severity of adverse effects can be increased when thiothixene is combined with chlormezanone.


The risk or severity of adverse effects can be increased when diflunisal is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when pergolide is combined with Topiroxostat.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with Salsalate.


The risk or severity of adverse effects can be increased when triprolidine is combined with levodopa.


The risk or severity of adverse effects can be increased when thiamylal is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when levodopa is combined with Flibanserin.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when GALLAMINE TRIETHIODIDE is combined with Cevimeline.


The risk or severity of adverse effects can be increased when GALLAMINE TRIETHIODIDE is combined with nicotine.


The risk or severity of adverse effects can be increased when bromazepam is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when sulindac is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when mesalamine is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when tubocurarine is combined with HYDROCODONE.


The risk or severity of adverse effects can be increased when HEROIN is combined with efavirenz.


The risk or severity of adverse effects can be increased when mecamylamine is combined with Bretylium.


The risk or severity of adverse effects can be increased when Remoxipride is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when Masoprocol is combined with Clobetasone.


The risk or severity of adverse effects can be increased when haloprogin is combined with eperisone.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with fexofenadine.


The risk or severity of adverse effects can be increased when rasagiline is combined with bupropion.


The risk or severity of adverse effects can be increased when diflorasone is combined with ambenonium.


The risk or severity of adverse effects can be increased when lorazepam is combined with tizanidine.


The risk or severity of adverse effects can be increased when thioridazine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when lorazepam is combined with flurazepam.


The risk or severity of adverse effects can be increased when oxycodone is combined with zotepine.


The risk or severity of adverse effects can be increased when aspirin is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with dantrolene.


The risk or severity of adverse effects can be increased when ibuprofen is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when cabergoline is combined with FLUPHENAZINE.


The risk or severity of adverse effects can be increased when cabergoline is combined with nicardipine.


The risk or severity of adverse effects can be increased when cabergoline is combined with efavirenz.


The risk or severity of adverse effects can be increased when cabergoline is combined with testosterone.


The risk or severity of adverse effects can be increased when furosemide is combined with carvedilol.


The risk or severity of adverse effects can be increased when enalapril is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with estazolam.


The risk or severity of adverse effects can be increased when lithium ion is combined with Tolcapone.


The risk or severity of adverse effects can be increased when phentolamine is combined with dipyridamole.


The risk or severity of adverse effects can be increased when Pramocaine is combined with tiapride.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when ethanol is combined with paroxetine.


The risk or severity of adverse effects can be increased when imipramine is combined with ESMOLOL.


The risk or severity of adverse effects can be increased when LISURIDE is combined with lansoprazole.


The risk or severity of adverse effects can be increased when quinapril is combined with alclofenac.


The risk or severity of adverse effects can be increased when Etidocaine is combined with butamben.


The risk or severity of adverse effects can be increased when LISURIDE is combined with betamethasone.


The risk or severity of adverse effects can be increased when scopolamine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when diazepam is combined with tetracaine.


The risk or severity of adverse effects can be increased when Telmisartan is combined with ADAPALENE.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with protriptyline.


The risk or severity of adverse effects can be increased when LISURIDE is combined with teniposide.


The risk or severity of adverse effects can be increased when methadone is combined with ERGOTAMINE.


The risk or severity of adverse effects can be increased when methadone is combined with furosemide.


The risk or severity of adverse effects can be increased when zaleplon is combined with Milnacipran.


The risk or severity of adverse effects can be increased when alprazolam is combined with tiapride.


The risk or severity of adverse effects can be increased when linezolid is combined with zotepine.


The risk or severity of adverse effects can be increased when linezolid is combined with MELPERONE.


The risk or severity of adverse effects can be increased when levorphanol is combined with Etidocaine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when methadone is combined with MELPERONE.


The risk or severity of adverse effects can be increased when Olopatadine is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when promazine is combined with Halazepam.


The risk or severity of adverse effects can be increased when promazine is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when chlormezanone is combined with nortriptyline.


The risk or severity of adverse effects can be increased when chlormezanone is combined with amoxapine.


The risk or severity of adverse effects can be increased when Olopatadine is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when Bortezomib is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when hydromorphone is combined with prochlorperazine.


The risk or severity of adverse effects can be increased when Bortezomib is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with tetracaine.


The risk or severity of adverse effects can be increased when tetracaine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with cetirizine.


The risk or severity of adverse effects can be increased when Olmesartan is combined with felodipine.


The risk or severity of adverse effects can be increased when Olmesartan is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when azelastine is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when BECLOMETHASONE DIPROPIONATE is combined with sparfloxacin.


The risk or severity of adverse effects can be increased when docetaxel is combined with sulindac.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with tretinoin.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when docetaxel is combined with Medroxyprogesterone acetate.


The risk or severity of adverse effects can be increased when quazepam is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Trabectedin.


The risk or severity of adverse effects can be increased when docetaxel is combined with Venetoclax.


The risk or severity of adverse effects can be increased when oxaprozin is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with pentostatin.


The risk or severity of adverse effects can be increased when Ephedrine is combined with PSEUDOEPHEDRINE.


The risk or severity of adverse effects can be increased when mecamylamine is combined with felodipine.


The risk or severity of adverse effects can be increased when docetaxel is combined with Bendamustine.


The risk or severity of adverse effects can be increased when dyclonine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when tubocurarine is combined with Mirabegron.


The risk or severity of adverse effects can be increased when Masoprocol is combined with medrysone.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with doxepin.


The risk or severity of adverse effects can be increased when Clofarabine is combined with mecamylamine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when pimozide is combined with triflupromazine.


The risk or severity of adverse effects can be increased when butorphanol is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when Arotinolol is combined with Torasemide.


The risk or severity of adverse effects can be increased when bepridil is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when carprofen is combined with resveratrol.


The risk or severity of adverse effects can be increased when aspirin is combined with ibuprofen.


The risk or severity of adverse effects can be increased when reserpine is combined with diazepam.


The risk or severity of adverse effects can be increased when Tramadol is combined with Lurasidone.


The risk or severity of adverse effects can be increased when hydroxyzine is combined with paroxetine.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with Pipamperone.


The risk or severity of adverse effects can be increased when fenoprofen is combined with flumethasone.


The risk or severity of adverse effects can be increased when Paliperidone is combined with fexofenadine.


The risk or severity of adverse effects can be increased when sulconazole is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when Micafungin is combined with manidipine.


The risk or severity of adverse effects can be increased when clemastine is combined with carisoprodol.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with raloxifene.


The risk or severity of adverse effects can be increased when Flupentixol is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when cabergoline is combined with GLYCEROL PHENYLBUTYRATE.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with Masoprocol.


The risk or severity of adverse effects can be increased when ketoprofen is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when Asenapine is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when Clevidipine is combined with Aliskiren.


The risk or severity of adverse effects can be increased when aspirin is combined with Apremilast.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when aspirin is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when Naftifine is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when Eprosartan is combined with nadolol.


The risk or severity of adverse effects can be increased when nortriptyline is combined with Arformoterol.


The risk or severity of adverse effects can be increased when Pramocaine is combined with nortriptyline.


The risk or severity of adverse effects can be increased when procarbazine is combined with dipivefrin.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when carprofen is combined with aspirin.


The risk or severity of adverse effects can be increased when protriptyline is combined with periciazine.


The risk or severity of adverse effects can be increased when clonidine is combined with meclizine.


The risk or severity of adverse effects can be increased when salicylamide is combined with halcinonide.


The risk or severity of adverse effects can be increased when salicylamide is combined with difluprednate.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with brotizolam.


The risk or severity of adverse effects can be increased when Melatonin is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when cilnidipine is combined with Torasemide.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when pentazocine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Pramocaine.


The risk or severity of adverse effects can be increased when carprofen is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when dexamethasone is combined with galanthamine.


The risk or severity of adverse effects can be increased when tubocurarine is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when dexamethasone is combined with Isoflurophate.


The risk or severity of adverse effects can be increased when vinblastine is combined with leflunomide.


The risk or severity of adverse effects can be increased when ibuprofen is combined with Icatibant.


The risk or severity of adverse effects can be increased when sulpiride is combined with cocaine.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with Propacetamol.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with Pramocaine.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when ketamine is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Efonidipine.


The risk or severity of adverse effects can be increased when RIFABUTIN is combined with clopidogrel.


The risk or severity of adverse effects can be increased when Lurasidone is combined with chlormezanone.


The risk or severity of adverse effects can be increased when Lurasidone is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with phentolamine.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when butabarbital is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with tizanidine.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with furosemide.


The risk or severity of adverse effects can be increased when pentazocine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with HEROIN.


The risk or severity of adverse effects can be increased when PIPECURONIUM is combined with nalbuphine.


The risk or severity of adverse effects can be increased when tolazoline is combined with apraclonidine.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with halcinonide.


The risk or severity of adverse effects can be increased when diazepam is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when phenobarbital is combined with mesoridazine.


The risk or severity of adverse effects can be increased when docetaxel is combined with Sunitinib.


The risk or severity of adverse effects can be increased when procyclidine is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when formestane is combined with ROSOXACIN.


The risk or severity of adverse effects can be increased when oxymorphone is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when suprofen is combined with medrysone.


The risk or severity of adverse effects can be increased when ketorolac is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when nimodipine is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when sulpiride is combined with zonisamide.


The risk or severity of adverse effects can be increased when sulindac is combined with desoximetasone.


The risk or severity of adverse effects can be increased when ATROPINE is combined with orphenadrine.


The risk or severity of adverse effects can be increased when THYMOL is combined with felodipine.


The risk or severity of adverse effects can be increased when tacrolimus is combined with ifosfamide.


The risk or severity of adverse effects can be increased when pargyline is combined with mianserin.


The risk or severity of adverse effects can be increased when levorphanol is combined with dibucaine.


The risk or severity of adverse effects can be increased when temazepam is combined with ethosuximide.


The risk or severity of adverse effects can be increased when cabergoline is combined with quinidine.


The risk or severity of adverse effects can be increased when levorphanol is combined with metolazone.


The risk or severity of adverse effects can be increased when Flupentixol is combined with benzocaine.


The risk or severity of adverse effects can be increased when apraclonidine is combined with Bretylium.


The risk or severity of adverse effects can be increased when ethotoin is combined with clidinium.


The risk or severity of adverse effects can be increased when Escitalopram is combined with Remoxipride.


The risk or severity of adverse effects can be increased when Pentolinium is combined with Tramadol.


The risk or severity of adverse effects can be increased when prazepam is combined with fluoxetine.


The risk or severity of adverse effects can be increased when clonidine is combined with promethazine.


The risk or severity of adverse effects can be increased when clonidine is combined with clonazepam.


The risk or severity of adverse effects can be increased when salicylic acid is combined with gabapentin.


The risk or severity of adverse effects can be increased when propoxyphene is combined with Mersalyl.


The risk or severity of adverse effects can be increased when salicylic acid is combined with oxaprozin.


The risk or severity of adverse effects can be increased when Propiverine is combined with codeine.


The risk or severity of adverse effects can be increased when mepivacaine is combined with clidinium.


The risk or severity of adverse effects can be increased when Naftifine is combined with nilvadipine.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when Flupentixol is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when benazepril is combined with Propacetamol.


The risk or severity of adverse effects can be increased when BISOPROLOL is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when Tedizolid phosphate is combined with thioridazine.


The risk or severity of adverse effects can be increased when losartan is combined with tolmetin.


The risk or severity of adverse effects can be increased when BISOPROLOL is combined with lisinopril.


The risk or severity of adverse effects can be increased when Phenelzine is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when Vilazodone is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with DALFOPRISTIN.


The risk or severity of adverse effects can be increased when Bortezomib is combined with fenoldopam.


The risk or severity of adverse effects can be increased when Conivaptan is combined with irbesartan.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with oxprenolol.


The risk or severity of adverse effects can be increased when prazepam is combined with clomipramine.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with etizolam.


The risk or severity of adverse effects can be increased when nimodipine is combined with nicardipine.


The risk or severity of adverse effects can be increased when methylergonovine is combined with metyrapone.


The risk or severity of adverse effects can be increased when Telmisartan is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when methylergonovine is combined with sulfamethoxazole.


The risk or severity of adverse effects can be increased when methylergonovine is combined with glyburide.


The risk or severity of adverse effects can be increased when medrysone is combined with physostigmine.


The risk or severity of adverse effects can be increased when buspirone is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with METHAMPHETAMINE.


The risk or severity of adverse effects can be increased when Rufinamide is combined with dantrolene.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with Pirlindole.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with Toloxatone.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when MELPERONE is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when Etomidate is combined with Normethadone.


The risk or severity of adverse effects can be increased when rasagiline is combined with clozapine.


The risk or severity of adverse effects can be increased when zaleplon is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when citalopram is combined with rasagiline.


The risk or severity of adverse effects can be increased when zaleplon is combined with Ramelteon.


The risk or severity of adverse effects can be increased when LISURIDE is combined with ifosfamide.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with zotepine.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with MELPERONE.


The risk or severity of adverse effects can be increased when LISURIDE is combined with pergolide.


The risk or severity of adverse effects can be increased when tretinoin is combined with fosinopril.


The risk or severity of adverse effects can be increased when loxapine is combined with dyclonine.


The risk or severity of adverse effects can be increased when propoxyphene is combined with atorvastatin.


The risk or severity of adverse effects can be increased when haloperidol is combined with pimozide.


The risk or severity of adverse effects can be increased when medrysone is combined with rivastigmine.


The risk or severity of adverse effects can be increased when isoflurane is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when isoflurane is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when propofol is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when hydromorphone is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when vigabatrin is combined with desipramine.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Tixocortol.


The risk or severity of adverse effects can be increased when tizanidine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when DESONIDE is combined with metoclopramide.


The risk or severity of adverse effects can be increased when lidocaine is combined with thiamylal.


The risk or severity of adverse effects can be increased when suprofen is combined with formestane.


The risk or severity of adverse effects can be increased when lidocaine is combined with halothane.


The risk or severity of adverse effects can be increased when Levetiracetam is combined with paroxetine.


The risk or severity of adverse effects can be increased when procarbazine is combined with bromocriptine.


The risk or severity of adverse effects can be increased when cilazapril is combined with sulindac.


The risk or severity of adverse effects can be increased when cilazapril is combined with chloroquine.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with Trovafloxacin.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with medrysone.


The risk or severity of adverse effects can be increased when flurazepam is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when Olmesartan is combined with rescinnamine.


The risk or severity of adverse effects can be increased when Tedizolid phosphate is combined with pimozide.


The risk or severity of adverse effects can be increased when zaleplon is combined with quazepam.


The risk or severity of adverse effects can be increased when etizolam is combined with tizanidine.


The risk or severity of adverse effects can be increased when Butethal is combined with phenytoin.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when zaleplon is combined with oxprenolol.


The risk or severity of adverse effects can be increased when mesoridazine is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when clozapine is combined with Efonidipine.


The risk or severity of adverse effects can be increased when METAXALONE is combined with clonazepam.


The risk or severity of adverse effects can be increased when dicyclomine is combined with Methylscopolamine bromide.


The risk or severity of adverse effects can be increased when HEROIN is combined with levodopa.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with azelastine.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with fexofenadine.


The risk or severity of adverse effects can be increased when tioconazole is combined with felodipine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when FLUOCORTOLONE is combined with rivastigmine.


The risk or severity of adverse effects can be increased when nefazodone is combined with moclobemide.


The risk or severity of adverse effects can be increased when Ibrutinib is combined with ACENOCOUMAROL.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with pentazocine.


The risk or severity of adverse effects can be increased when FLUOCORTOLONE is combined with physostigmine.


The risk or severity of adverse effects can be increased when Lurasidone is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with trazodone.


The risk or severity of adverse effects can be increased when meperidine is combined with lithium ion.


The risk or severity of adverse effects can be increased when GALLAMINE TRIETHIODIDE is combined with Butylscopolamine.


The risk or severity of adverse effects can be increased when etizolam is combined with cetirizine.


The risk or severity of adverse effects can be increased when risperidone is combined with ethotoin.


The risk or severity of adverse effects can be increased when Milnacipran is combined with Flupentixol.


The risk or severity of adverse effects can be increased when oxiconazole is combined with nicardipine.


The risk or severity of adverse effects can be increased when fluoxetine is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when pramipexole is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when proparacaine is combined with cetirizine.


The risk or severity of adverse effects can be increased when proparacaine is combined with protriptyline.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when diflunisal is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when hydromorphone is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when methylergonovine is combined with tacrolimus.


The risk or severity of adverse effects can be increased when triamterene is combined with metolazone.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with Olopatadine.


The risk or severity of adverse effects can be increased when methylergonovine is combined with ranitidine.


The risk or severity of adverse effects can be increased when triamterene is combined with CARTEOLOL.


The risk or severity of adverse effects can be increased when ATROPINE is combined with Vecuronium.


The risk or severity of adverse effects can be increased when methazolamide is combined with Aliskiren.


The risk or severity of adverse effects can be increased when perphenazine is combined with HEROIN.


The risk or severity of adverse effects can be increased when dicyclomine is combined with levorphanol.


The risk or severity of adverse effects can be increased when propofol is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when methscopolamine is combined with morphine.


The risk or severity of adverse effects can be increased when clomipramine is combined with Indacaterol.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when reserpine is combined with Pramocaine.


The risk or severity of adverse effects can be increased when nystatin is combined with Pinaverium.


The risk or severity of adverse effects can be increased when triprolidine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when reserpine is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when fluocinonide is combined with Deferasirox.


The risk or severity of adverse effects can be increased when halothane is combined with Clevidipine.


The risk or severity of adverse effects can be increased when hydrocortisone is combined with Gemifloxacin.


The risk or severity of adverse effects can be increased when cocaine is combined with ethosuximide.


The risk or severity of adverse effects can be increased when triflupromazine is combined with procaine.


The risk or severity of adverse effects can be increased when thiamylal is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when ropinirole is combined with Sacubitril.


The risk or severity of adverse effects can be increased when thiamylal is combined with Ramelteon.


The risk or severity of adverse effects can be increased when Propacetamol is combined with alclometasone.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with terazosin.


The risk or severity of adverse effects can be increased when HEROIN is combined with nortriptyline.


The risk or severity of adverse effects can be increased when HEROIN is combined with amoxapine.


The risk or severity of adverse effects can be increased when triamterene is combined with cilazapril.


The risk or severity of adverse effects can be increased when Nabilone is combined with Escitalopram.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with Pipamperone.


The risk or severity of adverse effects can be increased when equilin is combined with cinoxacin.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when ethosuximide is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with felbamate.


The risk or severity of adverse effects can be increased when nitrendipine is combined with quetiapine.


The risk or severity of adverse effects can be increased when sumatriptan is combined with doxepin.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with clemastine.


The risk or severity of adverse effects can be increased when imipramine is combined with efavirenz.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with venlafaxine.


The risk or severity of adverse effects can be increased when Normethadone is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when morniflumate is combined with floctafenine.


The risk or severity of adverse effects can be increased when nitrazepam is combined with olanzapine.


The risk or severity of adverse effects can be increased when bepridil is combined with Clevidipine.


The risk or severity of adverse effects can be increased when propantheline is combined with Tramadol.


The risk or severity of adverse effects can be increased when ketoconazole is combined with bepridil.


The risk or severity of adverse effects can be increased when MELPERONE is combined with phenytoin.


The risk or severity of adverse effects can be increased when ketoconazole is combined with eperisone.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with dipyridamole.


The risk or severity of adverse effects can be increased when procarbazine is combined with perphenazine.


The risk or severity of adverse effects can be increased when Etomidate is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when Etomidate is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when GUANFACINE is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when etodolac is combined with diflorasone.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with butamben.


The risk or severity of adverse effects can be increased when rescinnamine is combined with ADAPALENE.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when donepezil is combined with pilocarpine.


The risk or severity of adverse effects can be increased when thiamylal is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when Asenapine is combined with efavirenz.


The risk or severity of adverse effects can be increased when triazolam is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when diflunisal is combined with Tixocortol.


The risk or severity of adverse effects can be increased when Pomalidomide is combined with fluoxetine.


The risk or severity of adverse effects can be increased when Pomalidomide is combined with duloxetine.


The risk or severity of adverse effects can be increased when propofol is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when methazolamide is combined with apraclonidine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with topiramate.


The risk or severity of adverse effects can be increased when methazolamide is combined with Telmisartan.


The risk or severity of adverse effects can be increased when equilin is combined with Gemifloxacin.


The risk or severity of adverse effects can be increased when fenbufen is combined with Propacetamol.


The risk or severity of adverse effects can be increased when Caspofungin is combined with PERHEXILINE.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with loteprednol.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when ticlopidine is combined with TROLAMINE SALICYLATE.


The risk or severity of adverse effects can be increased when methazolamide is combined with methyldopa.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when hydrocortisone is combined with Trovafloxacin.


The risk or severity of adverse effects can be increased when olanzapine is combined with maprotiline.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with loratadine.


The risk or severity of adverse effects can be increased when ketoconazole is combined with Clevidipine.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when phenobarbital is combined with amisulpride.


The risk or severity of adverse effects can be increased when pentobarbital is combined with Desloratadine.


The risk or severity of adverse effects can be increased when carbamazepine is combined with tizanidine.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with ethotoin.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with epirizole.


The risk or severity of adverse effects can be increased when meclizine is combined with clidinium.


The risk or severity of adverse effects can be increased when lithium ion is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when amisulpride is combined with phenytoin.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with Etomidate.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with Flibanserin.


The risk or severity of adverse effects can be increased when valsartan is combined with Telmisartan.


The risk or severity of adverse effects can be increased when estazolam is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when Methylscopolamine bromide is combined with morphine.


The risk or severity of adverse effects can be increased when hydrocortisone is combined with mefloquine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with promethazine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with estrone.


The risk or severity of adverse effects can be increased when valsartan is combined with methyldopa.


The risk or severity of adverse effects can be increased when diclofenac is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when diclofenac is combined with amcinonide.


The risk or severity of adverse effects can be increased when pimozide is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when dibucaine is combined with carisoprodol.


The risk or severity of adverse effects can be increased when irbesartan is combined with Masoprocol.


The risk or severity of adverse effects can be increased when irbesartan is combined with ramipril.


The risk or severity of adverse effects can be increased when procyclidine is combined with ethopropazine.


The risk or severity of adverse effects can be increased when floctafenine is combined with Halobetasol.


The risk or severity of adverse effects can be increased when oxymorphone is combined with loratadine.


The risk or severity of adverse effects can be increased when clonazepam is combined with levodopa.


The risk or severity of adverse effects can be increased when oxybutynin is combined with propoxyphene.


The risk or severity of adverse effects can be increased when floctafenine is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when NATAMYCIN is combined with nisoldipine.


The risk or severity of adverse effects can be increased when bromazepam is combined with clonidine.


The risk or severity of adverse effects can be increased when floctafenine is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with perphenazine.


The risk or severity of adverse effects can be increased when triflupromazine is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when triflupromazine is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when Retigabine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when pimozide is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when bupivacaine is combined with tizanidine.


The risk or severity of adverse effects can be increased when baclofen is combined with trimipramine.


The risk or severity of adverse effects can be increased when bupivacaine is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when bupivacaine is combined with phentolamine.


The risk or severity of adverse effects can be increased when secobarbital is combined with citalopram.


The risk or severity of adverse effects can be increased when risperidone is combined with fludiazepam.


The risk or severity of adverse effects can be increased when Limaprost is combined with Ximelagatran.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with propofol.


The risk or severity of adverse effects can be increased when risperidone is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when citalopram is combined with tiapride.


The risk or severity of adverse effects can be increased when procaine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when Fospropofol is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when PIPECURONIUM is combined with Vecuronium.


The risk or severity of adverse effects can be increased when estazolam is combined with Halazepam.


The risk or severity of adverse effects can be increased when estazolam is combined with proparacaine.


The risk or severity of adverse effects can be increased when zopiclone is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when floctafenine is combined with triamcinolone.


The risk or severity of adverse effects can be increased when salicylamide is combined with haloperidol.


The risk or severity of adverse effects can be increased when prilocaine is combined with venlafaxine.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with ethosuximide.


The risk or severity of adverse effects can be increased when Naftifine is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when mecamylamine is combined with orphenadrine.


The risk or severity of adverse effects can be increased when morphine is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with deslanoside.


The risk or severity of adverse effects can be increased when zopiclone is combined with Difenoxin.


The risk or severity of adverse effects can be increased when alclofenac is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when pentamidine is combined with nifedipine.


The risk or severity of adverse effects can be increased when alclofenac is combined with Halobetasol.


The risk or severity of adverse effects can be increased when morphine is combined with proparacaine.


The risk or severity of adverse effects can be increased when lisinopril is combined with sulfasalazine.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with alclofenac.


The risk or severity of adverse effects can be increased when MAGNESIUM HYDROXIDE is combined with misoprostol.


The risk or severity of adverse effects can be increased when temazepam is combined with Paliperidone.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with dibucaine.


The risk or severity of adverse effects can be increased when trimipramine is combined with Arformoterol.


The risk or severity of adverse effects can be increased when lithium ion is combined with Lorcaserin.


The risk or severity of adverse effects can be increased when prilocaine is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with alclofenac.


The risk or severity of adverse effects can be increased when tenoxicam is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when tenoxicam is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with zotepine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when Rufinamide is combined with sevoflurane.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with thalidomide.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Gatifloxacin.


The risk or severity of adverse effects can be increased when secobarbital is combined with bromazepam.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with fludiazepam.


The risk or severity of adverse effects can be increased when apraclonidine is combined with carvedilol.


The risk or severity of adverse effects can be increased when amoxapine is combined with Cariprazine.


The risk or severity of adverse effects can be increased when Normethadone is combined with Torasemide.


The risk or severity of adverse effects can be increased when diltiazem is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when enflurane is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when mepivacaine is combined with sertraline.


The risk or severity of adverse effects can be increased when Eplerenone is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when ketorolac is combined with aspirin.


The risk or severity of adverse effects can be increased when Nepafenac is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when Nepafenac is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when Tramadol is combined with fexofenadine.


The risk or severity of adverse effects can be increased when Tramadol is combined with naratriptan.


The risk or severity of adverse effects can be increased when Tramadol is combined with rizatriptan.


The risk or severity of adverse effects can be increased when temazepam is combined with oxymorphone.


The risk or severity of adverse effects can be increased when secobarbital is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with Normethadone.


The risk or severity of adverse effects can be increased when Levomilnacipran is combined with Iloperidone.


The risk or severity of adverse effects can be increased when sotalol is combined with irbesartan.


The risk or severity of adverse effects can be increased when bupivacaine is combined with hydralazine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with methocarbamol.


The risk or severity of adverse effects can be increased when Trospium is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when sotalol is combined with felodipine.


The risk or severity of adverse effects can be increased when sumatriptan is combined with procarbazine.


The risk or severity of adverse effects can be increased when sotalol is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when moclobemide is combined with Salmeterol.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with enflurane.


The risk or severity of adverse effects can be increased when ATROPINE is combined with Metixene.


The risk or severity of adverse effects can be increased when flurazepam is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when Tedizolid phosphate is combined with olanzapine.


The risk or severity of adverse effects can be increased when moclobemide is combined with mesoridazine.


The risk or severity of adverse effects can be increased when fenoprofen is combined with halcinonide.


The risk or severity of adverse effects can be increased when fenoprofen is combined with difluprednate.


The risk or severity of adverse effects can be increased when moclobemide is combined with maprotiline.


The risk or severity of adverse effects can be increased when vigabatrin is combined with Milnacipran.


The risk or severity of adverse effects can be increased when reserpine is combined with butalbital.


The risk or severity of adverse effects can be increased when indomethacin is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when indomethacin is combined with Salsalate.


The risk or severity of adverse effects can be increased when Tramadol is combined with Articaine.


The risk or severity of adverse effects can be increased when Tixocortol is combined with mefloquine.


The risk or severity of adverse effects can be increased when pergolide is combined with Repaglinide.


The risk or severity of adverse effects can be increased when benzocaine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when prilocaine is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when pergolide is combined with metronidazole.


The risk or severity of adverse effects can be increased when proparacaine is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with triflupromazine.


The risk or severity of adverse effects can be increased when Torasemide is combined with carvedilol.


The risk or severity of adverse effects can be increased when linezolid is combined with promethazine.


The risk or severity of adverse effects can be increased when oxycodone is combined with etizolam.


The risk or severity of adverse effects can be increased when benzocaine is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when thioridazine is combined with Torasemide.


The risk or severity of adverse effects can be increased when methadone is combined with meperidine.


The risk or severity of adverse effects can be increased when ropinirole is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when furazolidone is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when isradipine is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when Tixocortol is combined with NEOSTIGMINE.


The risk or severity of adverse effects can be increased when clomipramine is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when methadone is combined with imipramine.


The risk or severity of adverse effects can be increased when Apremilast is combined with budesonide.


The risk or severity of adverse effects can be increased when pentazocine is combined with glutethimide.


The risk or severity of adverse effects can be increased when ISOSORBIDE DINITRATE is combined with quetiapine.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with paroxetine.


The risk or severity of adverse effects can be increased when celecoxib is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when oxazepam is combined with clidinium.


The risk or severity of adverse effects can be increased when dantrolene is combined with fluoxetine.


The risk or severity of adverse effects can be increased when topiramate is combined with efavirenz.


The risk or severity of adverse effects can be increased when dantrolene is combined with duloxetine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when tretinoin is combined with cilazapril.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with glutethimide.


The risk or severity of adverse effects can be increased when glutethimide is combined with topiramate.


The risk or severity of adverse effects can be increased when nitrazepam is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when nitrazepam is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when nitrazepam is combined with thiothixene.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with Desloratadine.


The risk or severity of adverse effects can be increased when phenobarbital is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when trimipramine is combined with Indacaterol.


The risk or severity of adverse effects can be increased when phentolamine is combined with pramipexole.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with tetracaine.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with amisulpride.


The risk or severity of adverse effects can be increased when levorphanol is combined with Efonidipine.


The risk or severity of adverse effects can be increased when chloroxine is combined with Pregabalin.


The risk or severity of adverse effects can be increased when Icatibant is combined with acemetacin.


The risk or severity of adverse effects can be increased when Tolcapone is combined with fosinopril.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with Butethal.


The risk or severity of adverse effects can be increased when MEPHENTERMINE is combined with clenbuterol.


The risk or severity of adverse effects can be increased when cyclopentolate is combined with Normethadone.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with losartan.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with lithium ion.


The risk or severity of adverse effects can be increased when reserpine is combined with digitoxin.


The risk or severity of adverse effects can be increased when Olopatadine is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when ketoprofen is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when meperidine is combined with D-mannitol.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with furosemide.


The risk or severity of adverse effects can be increased when PREDNICARBATE is combined with tubocurarine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with tizanidine.


The risk or severity of adverse effects can be increased when dicyclomine is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when quazepam is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when valsartan is combined with Nebivolol.


The risk or severity of adverse effects can be increased when indapamide is combined with digitoxin.


The risk or severity of adverse effects can be increased when Telmisartan is combined with BALSALAZIDE.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when indomethacin is combined with meclofenamic acid.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with enflurane.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when risperidone is combined with Normethadone.


The risk or severity of adverse effects can be increased when paroxetine is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when carprofen is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when indomethacin is combined with salicylic acid.


The risk or severity of adverse effects can be increased when docetaxel is combined with tegafur.


The risk or severity of adverse effects can be increased when Spirapril is combined with Apremilast.


The risk or severity of adverse effects can be increased when methadone is combined with polythiazide.


The risk or severity of adverse effects can be increased when morphine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when acemetacin is combined with Clobetasone.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with fenoldopam.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with nylidrin.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with clonidine.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with linezolid.


The risk or severity of adverse effects can be increased when nabumetone is combined with fluocinonide.


The risk or severity of adverse effects can be increased when midazolam is combined with cocaine.


The risk or severity of adverse effects can be increased when imipramine is combined with dextromethorphan.


The risk or severity of adverse effects can be increased when Propiverine is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when Flupentixol is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when bumetanide is combined with acebutolol.


The risk or severity of adverse effects can be increased when bumetanide is combined with captopril.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with topiramate.


The risk or severity of adverse effects can be increased when Remoxipride is combined with loratadine.


The risk or severity of adverse effects can be increased when pimozide is combined with etizolam.


The risk or severity of adverse effects can be increased when floctafenine is combined with diflunisal.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with cetirizine.


The risk or severity of adverse effects can be increased when thioridazine is combined with Butethal.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with metaproterenol.


The risk or severity of adverse effects can be increased when cabergoline is combined with Tapentadol.


The risk or severity of adverse effects can be increased when tretinoin is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when Ibrutinib is combined with Cangrelor.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with nilvadipine.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with dyclonine.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with zonisamide.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with tiagabine.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with cocaine.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with ondansetron.


The risk or severity of adverse effects can be increased when Apremilast is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when citalopram is combined with rizatriptan.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with celecoxib.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with bupivacaine.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when halothane is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with Etomidate.


The risk or severity of adverse effects can be increased when alprazolam is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when celecoxib is combined with paramethasone.


The risk or severity of adverse effects can be increased when thioridazine is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when isoflurane is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when Telmisartan is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when nalbuphine is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when nicergoline is combined with Phenelzine.


The risk or severity of adverse effects can be increased when oxaliplatin is combined with leflunomide.


The risk or severity of adverse effects can be increased when Tramadol is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when Levocetirizine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with clomipramine.


The risk or severity of adverse effects can be increased when barnidipine is combined with propofol.


The risk or severity of adverse effects can be increased when nalbuphine is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when reserpine is combined with trandolapril.


The risk or severity of adverse effects can be increased when fenoprofen is combined with medrysone.


The risk or severity of adverse effects can be increased when reserpine is combined with acetyldigitoxin.


The risk or severity of adverse effects can be increased when Telmisartan is combined with carprofen.


The risk or severity of adverse effects can be increased when Telmisartan is combined with nifedipine.


The risk or severity of adverse effects can be increased when pirenzepine is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when minoxidil is combined with lisinopril.


The risk or severity of adverse effects can be increased when Lercanidipine is combined with sotalol.


The risk or severity of adverse effects can be increased when buspirone is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with ACETOPHENAZINE.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with ethotoin.


The risk or severity of adverse effects can be increased when minoxidil is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when ethotoin is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when buspirone is combined with proparacaine.


The risk or severity of adverse effects can be increased when Halazepam is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when carprofen is combined with Clobetasone.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with loteprednol.


The risk or severity of adverse effects can be increased when perphenazine is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when Lercanidipine is combined with Nabilone.


The risk or severity of adverse effects can be increased when Treprostinil is combined with Apremilast.


The risk or severity of adverse effects can be increased when oxiconazole is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when nicergoline is combined with nitric oxide.


The risk or severity of adverse effects can be increased when HYDROCODONE is combined with Alvimopan.


The risk or severity of adverse effects can be increased when hydromorphone is combined with maprotiline.


The risk or severity of adverse effects can be increased when Pirlindole is combined with isoetharine.


The risk or severity of adverse effects can be increased when alprazolam is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with Darunavir.


The risk or severity of adverse effects can be increased when felodipine is combined with captopril.


The risk or severity of adverse effects can be increased when metolazone is combined with Riociguat.


The risk or severity of adverse effects can be increased when felodipine is combined with acebutolol.


The risk or severity of adverse effects can be increased when nitric oxide is combined with atenolol.


The risk or severity of adverse effects can be increased when naratriptan is combined with selegiline.


The risk or severity of adverse effects can be increased when amphotericin b is combined with thioridazine.


The risk or severity of adverse effects can be increased when pentazocine is combined with Conivaptan.


The risk or severity of adverse effects can be increased when hydromorphone is combined with mesoridazine.


The risk or severity of adverse effects can be increased when prazepam is combined with vigabatrin.


The risk or severity of adverse effects can be increased when trandolapril is combined with meclofenamic acid.


The risk or severity of adverse effects can be increased when tenoxicam is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when prazosin is combined with tizanidine.


The risk or severity of adverse effects can be increased when barnidipine is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when tenoxicam is combined with Salsalate.


The risk or severity of adverse effects can be increased when Melatonin is combined with amoxapine.


The risk or severity of adverse effects can be increased when Melatonin is combined with nortriptyline.


The risk or severity of adverse effects can be increased when tubocurarine is combined with meperidine.


The risk or severity of adverse effects can be increased when SULFAMOXOLE is combined with mecamylamine.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when niflumic acid is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with benzocaine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Difenoxin.


The risk or severity of adverse effects can be increased when pentazocine is combined with Mersalyl.


The risk or severity of adverse effects can be increased when ethopropazine is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with vigabatrin.


The risk or severity of adverse effects can be increased when cocaine is combined with lithium ion.


The risk or severity of adverse effects can be increased when cetirizine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when Treprostinil is combined with ketoprofen.


The risk or severity of adverse effects can be increased when cocaine is combined with Butethal.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Mersalyl.


The risk or severity of adverse effects can be increased when nabumetone is combined with alclometasone.


The risk or severity of adverse effects can be increased when papaverine is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when antipyrine is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when acebutolol is combined with pilocarpine.


The risk or severity of adverse effects can be increased when butabarbital is combined with dantrolene.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when olanzapine is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Pipamperone.


The risk or severity of adverse effects can be increased when nicergoline is combined with bifonazole.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with clonidine.


The risk or severity of adverse effects can be increased when pentobarbital is combined with Articaine.


The risk or severity of adverse effects can be increased when alprazolam is combined with Iloperidone.


The risk or severity of adverse effects can be increased when Olopatadine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when levodopa is combined with rasagiline.


The risk or severity of adverse effects can be increased when Olopatadine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when butalbital is combined with flunarizine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Agomelatine.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with tiapride.


The risk or severity of adverse effects can be increased when Clobetasone is combined with malathion.


The risk or severity of adverse effects can be increased when diazepam is combined with ondansetron.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with efavirenz.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with budesonide.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with sertraline.


The risk or severity of adverse effects can be increased when benztropine is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when Rufinamide is combined with efavirenz.


The risk or severity of adverse effects can be increased when Rufinamide is combined with FLUPHENAZINE.


The risk or severity of adverse effects can be increased when suprofen is combined with ibuprofen.


The risk or severity of adverse effects can be increased when Remoxipride is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when Rufinamide is combined with clorazepate.


The risk or severity of adverse effects can be increased when salicylic acid is combined with alclometasone.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when protriptyline is combined with PIRBUTEROL.


The risk or severity of adverse effects can be increased when HEROIN is combined with selegiline.


The risk or severity of adverse effects can be increased when budesonide is combined with NEOSTIGMINE.


The risk or severity of adverse effects can be increased when levorphanol is combined with pimozide.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with Desloratadine.


The risk or severity of adverse effects can be increased when nitric oxide is combined with thalidomide.


The risk or severity of adverse effects can be increased when Masoprocol is combined with diflunisal.


The risk or severity of adverse effects can be increased when zopiclone is combined with zonisamide.


The risk or severity of adverse effects can be increased when zopiclone is combined with cocaine.


The risk or severity of adverse effects can be increased when zopiclone is combined with tiagabine.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with Fospropofol.